Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

Boehringer Ingelheim

Status: Completed

Conditions: Osteoarthritis

Treatments: Drug: Synvisc®

Study type: Observational

Funder types: Industry

Identifiers

NCT02195544

1139.5

Details and patient eligibility

About

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

Enrollment: 70 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• not applicable

Exclusion criteria

• none

Trial design

70 participants in 1 patient group

Synvisc®

Treatment:

Drug: Synvisc®